Frequency and impact of autosomal dominant polycystic kidney disease in the Seychelles (Indian Ocean)

Nephrology Dialysis Transplantation

Volumn 12, Issue 10, 1997, Pages 2069-2074

  Yersin, C ^a   Bovet, P ^b,c   Wauters, J P ^d   Schorderet, D F ^d   Pescia, G ^d   Paccaud, F ^c  

^a Victoria Hospital   (Seychelles)

^b MINISTRY OF HEALTH   (Seychelles)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Africa; Autosomal dominant polycystic kidney disease; Developing countries; DNA analysis; Epidemiology; Hypertension; Renal failure

Indexed keywords

CREATININE; DNA FRAGMENT;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CAUCASIAN; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; HAPLOTYPE; HUMAN; KIDNEY POLYCYSTIC DISEASE; NEGRO; PREVALENCE; PRIORITY JOURNAL; SEYCHELLES;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; CHILD; DNA FRAGMENTATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HAPLOTYPES; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MORTALITY; PEDIGREE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREVALENCE; SEYCHELLES;

EID: 0030755208     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.10.2069     Document Type: Article

References (33)

1. Dalgaard OZ. Bilateral polycystic disease of the kidneys: a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand 1957; 328: 1-255
2. Gabow PA. Autosomal Dominant Polycystic Kidney Disease. N Eng J Med 1993; 329(5): 332-340
3. Grünfeld JP, Bennett WM. Clinical aspects of autosomal dominant polycystic kidney disease. Curr Opin Nephrol Hypertens 1995; 4: 114-120
4. Milutinovic J, Fialkow PJ, Rudd TG, Agodoa LY, Phillips LA, Bryant JI. Liver cysts in patients with autosomal dominant polycystic kidney disease. Am J Med 1980; 68(5): 741-744
5. Leier CV, Baker PB, Kilman JW, Wooley CF. Cardiovascular abnormalities associated with adult polycystic kidney disease. Ann Intern Med 1984; 100: 683-688
6. Ritz E, Zeier W, Schneider P, Jones E. Cardiovascular mortality of patients with polycystic kidney disease on dialysis: is there a lesson to learn? Nephron 1994; 66: 125-128
7. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease. Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 1983; 2(6): 630-639
8. Ministry of Information and Statistics Division. Census 1994. Victoria, Seychelles
9. Bovet P, Rosalie D, Shamlaye C, Darioli R, Paccaud F. The Seychelles Cardiovascular Disease Study. Soz Praventivmed 1991; 36[Suppl. 1]: S3-7
10. Management & Information Systems Division. Statistical Abstract 1992. Victoria, Seychelles
11. Parfrey PS, Bear JC, Morgan J et al. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 1990; 323(16): 1085-1090
12. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994; 343: 824-827
13. Harris PC, Thomas S, Ratcliffe PJ, Breuning MH, Coto E, Lopez-Larrea C. Rapide genetic analysis of families with polycystic kidney disease 1 by means of a microsatellite marker. Lancet 1991; 338: 1484-1487
14. Peral B, Ward CJ, San Millan JL et al. Evidence of linkage disequilibrium in the Spanish polycystic kidney disease 1 population. Am J Hum Genet 1994; 54: 899-908
15. Bovet P, Shamlaye C, Kitua A, Riesen WF, Paccaud F, Darioli R. High prevalence of cardiovascular risk factors in the Seychelles (Indian Ocean). Arterioscler Thromb 1991; 11: 1730-1736
16. Davies F, Coles GA, Harper PS, Williams AJ, Evans C, Cochlin D. Polycystic kidney disease re-evaluated: a population-based study. Q J Med 1991; 79: 477-485
17. Simon P, Le Goff JY, Ang KS, Charasse P, Le Cacheux P, Cam G. Données épidémiologiques, cliniques et pronostiques de la maladie polykystique autosomique dominante dans une région française. Néphrologie 1996; 17: 123-130
18. Heyer E, Trembley M. Variability of the genetic contribution of Quebec population founders associated to some deleterious genes. Am J Hum Genet 1995; 56(4): 970-978
19. Ka MM, Sow MT, Pouye A, Gueye SM, Ndiaye MF, Bao O. Polycystic kidney. Clinical and familial aspects, a propos of 29 cases. Dakar Med 1991; 36(1): 30-38
20. Habte B, Abraha A. Adult polycystic kidney disease in Ethiopians. Ethiop Med J 1983; 21(3): 193-196
21. Yium J, Gabow P, Johnson A, Kimberling W, Martinez-Maldonado M. Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin. J Am Soc Nephrol 1994; 4(9): 1670-1674
22. Gonzalo A, Rivera M, Quereda C, Ortuno J. Clinical features and prognosis of adult polycystic kidney disease. Am J Nephrol 1990; 10(6): 470-474
23. Ravine D, Walker RG, Gibson RN, Sheffield LJ, Kincaid-Smith P. Treatable complications in undiagnosed cases of autosomal dominant polycystic kidney disease. Lancet 1991; 337(8734): 127-129
24. Andersen S, Lindqvist B, Nystrom L. Prognosis curves for patients with polycystic kidney disease. Ann Clin Res 1982; 14(2): 90-92
25. Franz KA, Reubi FC. Rate of functional deterioration in polycystic kidney disease. Kidney Int 1983; 23: 526-529
26. Fick GM, Duley IT, Johnson AM, Strain JD, Manco-Johnson ML, Gabow PA. The spectrum of autosomal dominant polycystic kidney disease in children. J Am Soc Nephrol 1994; 4(9): 1654-1660
27. Bear JC, Parfrey PS, Morgan JM, Martin CJ, Cramer BC. Autosomal dominant polycystic kidney disease: new information for genetic counselling. Am J Med Genet 1992; 43: 548-553
28. Zeier M, Geberth S, Schmidt KG, Mandelbaum A, Ritz E. Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1993; 3: 1451-1457
29. Parfrey PS, Barrett BJ. Hypertension in autosomal dominant polycystic kidney disease. Curr Opin Nephrol Hypertens 1995; 4: 460-464
30. Sujansky E, Kreutzer SB, Johnson AM, Lezotte DC, Schrier RW, Gabow PA. Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. Am J Med Genet 1990; 26: 283-293
31. Mroczek WJ, Davidov M, Gavrilovich L, Finnerty FAJ. The value of aggressive therapy in the hypertensive patient with azotemia. Circulation 1969; 40: 893-904
32. Gonzalo A, Gallego A, Rivera M, Orte L, Ortuno J. Influence of hypertension on early renal insufficiency in autosomal dominant polycystic kidney disease. Nephron 1996; 72: 225-230
33. Salvadori M, Bandini S, Bertoni E, Piperno R, Rosati A, Tosi P. Clinical features and outcome of ADPKD patients after renal transplantation. Contrib Nephrol 1995; 115: 141-143